Enter a bar or public place and gauge opinions about cannabis and there will be a different opinion for each person questioned. Some ideas will be well-informed from reputable sources, while others will not be formed on any basis. Certainly, investigation and conclusions based on the research is difficult given the long history of illegality. Nevertheless, there is a tidal wave that cannabis is good and should be legalized. Many states in America and Australia have embarked on legalizing cannabis. Other countries are following suit or considering options. So what’s the position now? Is it good or not?
The National Academy of Sciences published a 487-page report (NAP Report) this year on the current state of evidence on the subject. Many government grants supported the committee’s work, an eminent collection of 16 professors. Fifteen academic reviewers kept them, and about 700 relevant publications were considered. The report is therefore seen as state-of-the-art in medical and recreational use. This article relies heavily on this source.
The term cannabis is loosely used here to denote cannabis and marijuana, the latter coming from a different part of the plant. More than 100 chemical compounds are found in cannabis, each with other benefits or risks.
CLINICAL INDICATIONS
Someone “stoned” from smoking cannabis may experience a euphoric state where time is irrelevant. Music and colors take on greater significance. The person may get the “nibblies” and eat sweet and fatty foods. This is often associated with impaired motor skills and perception. When high blood concentrations are reached, paranoid thoughts, hallucinations, and panic attacks can be “trip” features.
PURITY
Popularly, cannabis is often characterized as “good shit” and “bad shit,” referring to widespread contagion practices. The contaminants can come from soil quality (e.g., pesticides and heavy metals) or be added afterward. Sometimes lead particles or small glass beads to increase the weight sold.
THERAPEUTIC EFFECTS
A random selection of therapeutic effects appears here in the context of their evidence status. Some products will be shown to be beneficial, while others carry risks. Some products are barely distinguishable from the placebos of the study.
CANCER
The NAP report highlights the following cancer findings:
RESPIRATORY DISEASE
The NAP report highlights the following findings on the issue of respiratory diseases:
IMMUNE SYSTEM
The NAP report highlights the following findings on the human immune system issue:
MORTALITY
The NAP report highlights the following findings on the issue of the increased risk of death or injury:
BRAIN FUNCTION
The NAP report highlights the following findings on the issue of cognitive performance and mental health:
It should be reasonably clear from the foregoing that cannabis is not the panacea for all the health problems that some well-meaning but unwise cannabis proponents would have us believe. Still, the product offers a lot of hope. Thorough research can help clarify the issues. The NAP report is a solid step in the right direction. Unfortunately, there are still many barriers to researching this amazing drug. Over time, the benefits and risks will be more fully understood. Trust in the product will increase and many of the barriers, social and academic, will fall by the wayside.
After about 6 years of purchasing women’s clothing from China, India, Thailand, Bangladesh and Indonesia, we found a need to ensure the delivery is as follows:
• No child labor
• No cancer-causing azo dyes
• No harsh processing chemicals that harm the environment.
• Fabric from renewable sources
• Natural fire retardant fabric
We went one step further and asked ourselves:
what can we add to our range of clothing that improves the well-being of the wearer?
We came up with surprising answers. View this space.
diana-ware and wellness-wear
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |